2594. Rate of Methicillin-Resistant Staphylococcus aureus Infection Among Patients Hospitalized for Community-Acquired Pneumonia Article Swipe
Rachel Poole
,
Helen Lee
,
Steven Park
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/ofid/ofad500.2209
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1093/ofid/ofad500.2209
Background National clinical practice guidelines for community-acquired pneumonia (CAP) suggest empiric treatment for methicillin-resistant Staphylococcus aureus (MRSA) among hospitalized patients with risk factors including prior respiratory isolation of MRSA, recent hospitalization with receipt of IV antibiotics within 90 days, or based on a locally validated model. This study aims to assess the rate of MRSA infection among patients hospitalized with CAP to aid clinical decision-making regarding empiric treatment. Methods This is a retrospective, observational, population-based, descriptive study at an academic medical center. Patients will be included in the study if they were admitted between 1/01/2021 to 3/18/2023, are at least 18 years old, present with bacterial pneumonia, have a respiratory or blood culture obtained within 48 hours of admission, and complete an MRSA nasal screen, stratified by admission to an ICU vs. non-ICU ward. The primary outcome will be the rate of MRSA infection in patients hospitalized for CAP. The secondary outcome is to determine the negative predictive value (NPV) of MRSA nasal screening. Subgroup analyses will be performed for patients with respiratory MRSA isolation within 1 year of admission, mechanical ventilation within 24 hours of admission, and IV antibiotic use within 90 days of admission. Results A total of 1,053 patients met inclusion criteria for the study. The overall rate of MRSA infection was 3.3% (16/490) for ICU patients and 1.1% (6/563) for non-ICU patients. In patients with prior respiratory MRSA isolation, prevalence was 0% (0/7) and 28.6% (2/7) for the ICU and non-ICU groups, respectively. Among mechanically ventilated patients, prevalence was 2% (9/457). For prior IV antibiotic recipients, prevalence was 2.8% (3/109) and 0.5% (1/189) for the ICU and non-ICU groups, respectively. The combined NPV of MRSA nasal screening was 99%. Conclusion Overall prevalence of MRSA infection was low among patients hospitalized for CAP, without excluding patients based on underlying comorbid conditions or admission from a skilled nursing facility. MRSA nasal screening was associated with an overall high NPV. Empiric use of vancomycin is unlikely to be warranted for most patients admitted for CAP at our institution. Disclosures All Authors: No reported disclosures
Related Topics
Concepts
Medicine
Methicillin-resistant Staphylococcus aureus
Community-acquired pneumonia
Pneumonia
Internal medicine
Staphylococcus aureus
Population
Antibiotics
Retrospective cohort study
Intensive care medicine
Emergency medicine
Genetics
Environmental health
Biology
Microbiology
Bacteria
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/ofid/ofad500.2209
- https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.2209/53769321/ofad500.2209.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4389029199
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4389029199Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/ofid/ofad500.2209Digital Object Identifier
- Title
-
2594. Rate of Methicillin-Resistant Staphylococcus aureus Infection Among Patients Hospitalized for Community-Acquired PneumoniaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-11-27Full publication date if available
- Authors
-
Rachel Poole, Helen Lee, Steven ParkList of authors in order
- Landing page
-
https://doi.org/10.1093/ofid/ofad500.2209Publisher landing page
- PDF URL
-
https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.2209/53769321/ofad500.2209.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.2209/53769321/ofad500.2209.pdfDirect OA link when available
- Concepts
-
Medicine, Methicillin-resistant Staphylococcus aureus, Community-acquired pneumonia, Pneumonia, Internal medicine, Staphylococcus aureus, Population, Antibiotics, Retrospective cohort study, Intensive care medicine, Emergency medicine, Genetics, Environmental health, Biology, Microbiology, BacteriaTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4389029199 |
|---|---|
| doi | https://doi.org/10.1093/ofid/ofad500.2209 |
| ids.doi | https://doi.org/10.1093/ofid/ofad500.2209 |
| ids.openalex | https://openalex.org/W4389029199 |
| fwci | 0.0 |
| type | article |
| title | 2594. Rate of Methicillin-Resistant Staphylococcus aureus Infection Among Patients Hospitalized for Community-Acquired Pneumonia |
| biblio.issue | Supplement_2 |
| biblio.volume | 10 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10654 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9962000250816345 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Pneumonia and Respiratory Infections |
| topics[1].id | https://openalex.org/T10195 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9860000014305115 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | Antimicrobial Resistance in Staphylococcus |
| topics[2].id | https://openalex.org/T11681 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9830999970436096 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2706 |
| topics[2].subfield.display_name | Critical Care and Intensive Care Medicine |
| topics[2].display_name | Nosocomial Infections in ICU |
| is_xpac | False |
| apc_list.value | 3064 |
| apc_list.currency | USD |
| apc_list.value_usd | 3064 |
| apc_paid.value | 3064 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3064 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9457058906555176 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777052132 |
| concepts[1].level | 4 |
| concepts[1].score | 0.6599496006965637 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q595158 |
| concepts[1].display_name | Methicillin-resistant Staphylococcus aureus |
| concepts[2].id | https://openalex.org/C2776102371 |
| concepts[2].level | 3 |
| concepts[2].score | 0.63747239112854 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q460030 |
| concepts[2].display_name | Community-acquired pneumonia |
| concepts[3].id | https://openalex.org/C2777914695 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6268130540847778 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12192 |
| concepts[3].display_name | Pneumonia |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.558013916015625 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C2779489039 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4811614453792572 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q188121 |
| concepts[5].display_name | Staphylococcus aureus |
| concepts[6].id | https://openalex.org/C2908647359 |
| concepts[6].level | 2 |
| concepts[6].score | 0.44366514682769775 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[6].display_name | Population |
| concepts[7].id | https://openalex.org/C501593827 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4367121458053589 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12187 |
| concepts[7].display_name | Antibiotics |
| concepts[8].id | https://openalex.org/C167135981 |
| concepts[8].level | 2 |
| concepts[8].score | 0.42426547408103943 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2146302 |
| concepts[8].display_name | Retrospective cohort study |
| concepts[9].id | https://openalex.org/C177713679 |
| concepts[9].level | 1 |
| concepts[9].score | 0.38136065006256104 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[9].display_name | Intensive care medicine |
| concepts[10].id | https://openalex.org/C194828623 |
| concepts[10].level | 1 |
| concepts[10].score | 0.36058908700942993 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q2861470 |
| concepts[10].display_name | Emergency medicine |
| concepts[11].id | https://openalex.org/C54355233 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[11].display_name | Genetics |
| concepts[12].id | https://openalex.org/C99454951 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[12].display_name | Environmental health |
| concepts[13].id | https://openalex.org/C86803240 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[13].display_name | Biology |
| concepts[14].id | https://openalex.org/C89423630 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[14].display_name | Microbiology |
| concepts[15].id | https://openalex.org/C523546767 |
| concepts[15].level | 2 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q10876 |
| concepts[15].display_name | Bacteria |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9457058906555176 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/methicillin-resistant-staphylococcus-aureus |
| keywords[1].score | 0.6599496006965637 |
| keywords[1].display_name | Methicillin-resistant Staphylococcus aureus |
| keywords[2].id | https://openalex.org/keywords/community-acquired-pneumonia |
| keywords[2].score | 0.63747239112854 |
| keywords[2].display_name | Community-acquired pneumonia |
| keywords[3].id | https://openalex.org/keywords/pneumonia |
| keywords[3].score | 0.6268130540847778 |
| keywords[3].display_name | Pneumonia |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.558013916015625 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/staphylococcus-aureus |
| keywords[5].score | 0.4811614453792572 |
| keywords[5].display_name | Staphylococcus aureus |
| keywords[6].id | https://openalex.org/keywords/population |
| keywords[6].score | 0.44366514682769775 |
| keywords[6].display_name | Population |
| keywords[7].id | https://openalex.org/keywords/antibiotics |
| keywords[7].score | 0.4367121458053589 |
| keywords[7].display_name | Antibiotics |
| keywords[8].id | https://openalex.org/keywords/retrospective-cohort-study |
| keywords[8].score | 0.42426547408103943 |
| keywords[8].display_name | Retrospective cohort study |
| keywords[9].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[9].score | 0.38136065006256104 |
| keywords[9].display_name | Intensive care medicine |
| keywords[10].id | https://openalex.org/keywords/emergency-medicine |
| keywords[10].score | 0.36058908700942993 |
| keywords[10].display_name | Emergency medicine |
| language | en |
| locations[0].id | doi:10.1093/ofid/ofad500.2209 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2735126445 |
| locations[0].source.issn | 2328-8957 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2328-8957 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Open Forum Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| locations[0].source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.2209/53769321/ofad500.2209.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Open Forum Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1093/ofid/ofad500.2209 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:10677728 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | cc-by |
| locations[1].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10677728/pdf/ofad500.2209.pdf |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Open Forum Infect Dis |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10677728 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5109658748 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Rachel Poole |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210137750 |
| authorships[0].affiliations[0].raw_affiliation_string | UCI Health , Orange, California |
| authorships[0].institutions[0].id | https://openalex.org/I4210137750 |
| authorships[0].institutions[0].ror | https://ror.org/03fgher32 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210137750 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | UC Irvine Health |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Rachel M Poole |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | UCI Health , Orange, California |
| authorships[1].author.id | https://openalex.org/A5062646947 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2379-6940 |
| authorships[1].author.display_name | Helen Lee |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210137750 |
| authorships[1].affiliations[0].raw_affiliation_string | UCI Health , Orange, California |
| authorships[1].institutions[0].id | https://openalex.org/I4210137750 |
| authorships[1].institutions[0].ror | https://ror.org/03fgher32 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210137750 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | UC Irvine Health |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Helen Lee |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | UCI Health , Orange, California |
| authorships[2].author.id | https://openalex.org/A5101540262 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1554-1240 |
| authorships[2].author.display_name | Steven Park |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I204250578 |
| authorships[2].affiliations[0].raw_affiliation_string | University of California , Irvine, Irvine, California |
| authorships[2].institutions[0].id | https://openalex.org/I204250578 |
| authorships[2].institutions[0].ror | https://ror.org/04gyf1771 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I204250578 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | University of California, Irvine |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Steven Park |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | University of California , Irvine, Irvine, California |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.2209/53769321/ofad500.2209.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 2594. Rate of Methicillin-Resistant Staphylococcus aureus Infection Among Patients Hospitalized for Community-Acquired Pneumonia |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10654 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9962000250816345 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Pneumonia and Respiratory Infections |
| related_works | https://openalex.org/W2424689884, https://openalex.org/W2152296659, https://openalex.org/W4324144766, https://openalex.org/W2532901088, https://openalex.org/W1989107371, https://openalex.org/W1995533152, https://openalex.org/W2949380608, https://openalex.org/W2553858235, https://openalex.org/W2352957210, https://openalex.org/W2380056497 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/ofid/ofad500.2209 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2735126445 |
| best_oa_location.source.issn | 2328-8957 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2328-8957 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Open Forum Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| best_oa_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.2209/53769321/ofad500.2209.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Open Forum Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1093/ofid/ofad500.2209 |
| primary_location.id | doi:10.1093/ofid/ofad500.2209 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2735126445 |
| primary_location.source.issn | 2328-8957 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2328-8957 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Open Forum Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| primary_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://academic.oup.com/ofid/article-pdf/10/Supplement_2/ofad500.2209/53769321/ofad500.2209.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Open Forum Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1093/ofid/ofad500.2209 |
| publication_date | 2023-11-27 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 177 |
| abstract_inverted_index.A | 198 |
| abstract_inverted_index.a | 43, 72, 109, 308 |
| abstract_inverted_index.0% | 236 |
| abstract_inverted_index.18 | 101 |
| abstract_inverted_index.2% | 254 |
| abstract_inverted_index.24 | 184 |
| abstract_inverted_index.48 | 116 |
| abstract_inverted_index.90 | 38, 193 |
| abstract_inverted_index.IV | 35, 189, 258 |
| abstract_inverted_index.In | 227 |
| abstract_inverted_index.No | 343 |
| abstract_inverted_index.an | 79, 122, 130, 318 |
| abstract_inverted_index.at | 78, 99, 337 |
| abstract_inverted_index.be | 85, 139, 168, 329 |
| abstract_inverted_index.by | 127 |
| abstract_inverted_index.if | 90 |
| abstract_inverted_index.in | 87, 145 |
| abstract_inverted_index.is | 71, 153, 326 |
| abstract_inverted_index.of | 28, 34, 54, 118, 142, 161, 179, 186, 195, 200, 212, 278, 287, 324 |
| abstract_inverted_index.on | 42, 301 |
| abstract_inverted_index.or | 40, 111, 305 |
| abstract_inverted_index.to | 50, 62, 96, 129, 154, 328 |
| abstract_inverted_index.All | 341 |
| abstract_inverted_index.CAP | 61, 336 |
| abstract_inverted_index.For | 256 |
| abstract_inverted_index.ICU | 131, 219, 243, 270 |
| abstract_inverted_index.NPV | 277 |
| abstract_inverted_index.The | 135, 150, 209, 275 |
| abstract_inverted_index.aid | 63 |
| abstract_inverted_index.and | 120, 188, 221, 238, 244, 265, 271 |
| abstract_inverted_index.are | 98 |
| abstract_inverted_index.for | 6, 13, 148, 170, 206, 218, 224, 241, 268, 295, 331, 335 |
| abstract_inverted_index.low | 291 |
| abstract_inverted_index.met | 203 |
| abstract_inverted_index.our | 338 |
| abstract_inverted_index.the | 52, 88, 140, 156, 207, 242, 269 |
| abstract_inverted_index.use | 191, 323 |
| abstract_inverted_index.vs. | 132 |
| abstract_inverted_index.was | 215, 235, 253, 262, 282, 290, 315 |
| abstract_inverted_index.0.5% | 266 |
| abstract_inverted_index.1.1% | 222 |
| abstract_inverted_index.2.8% | 263 |
| abstract_inverted_index.3.3% | 216 |
| abstract_inverted_index.99%. | 283 |
| abstract_inverted_index.CAP, | 296 |
| abstract_inverted_index.CAP. | 149 |
| abstract_inverted_index.MRSA | 55, 123, 143, 162, 174, 213, 232, 279, 288, 312 |
| abstract_inverted_index.NPV. | 321 |
| abstract_inverted_index.This | 47, 70 |
| abstract_inverted_index.aims | 49 |
| abstract_inverted_index.days | 194 |
| abstract_inverted_index.from | 307 |
| abstract_inverted_index.have | 108 |
| abstract_inverted_index.high | 320 |
| abstract_inverted_index.most | 332 |
| abstract_inverted_index.old, | 103 |
| abstract_inverted_index.rate | 53, 141, 211 |
| abstract_inverted_index.risk | 22 |
| abstract_inverted_index.they | 91 |
| abstract_inverted_index.were | 92 |
| abstract_inverted_index.will | 84, 138, 167 |
| abstract_inverted_index.with | 21, 32, 60, 105, 172, 229, 317 |
| abstract_inverted_index.year | 178 |
| abstract_inverted_index.(0/7) | 237 |
| abstract_inverted_index.(2/7) | 240 |
| abstract_inverted_index.(CAP) | 9 |
| abstract_inverted_index.(NPV) | 160 |
| abstract_inverted_index.1,053 | 201 |
| abstract_inverted_index.28.6% | 239 |
| abstract_inverted_index.Among | 248 |
| abstract_inverted_index.MRSA, | 29 |
| abstract_inverted_index.among | 18, 57, 292 |
| abstract_inverted_index.based | 41, 300 |
| abstract_inverted_index.blood | 112 |
| abstract_inverted_index.days, | 39 |
| abstract_inverted_index.hours | 117, 185 |
| abstract_inverted_index.least | 100 |
| abstract_inverted_index.nasal | 124, 163, 280, 313 |
| abstract_inverted_index.prior | 25, 230, 257 |
| abstract_inverted_index.study | 48, 77, 89 |
| abstract_inverted_index.total | 199 |
| abstract_inverted_index.value | 159 |
| abstract_inverted_index.ward. | 134 |
| abstract_inverted_index.years | 102 |
| abstract_inverted_index.(MRSA) | 17 |
| abstract_inverted_index.assess | 51 |
| abstract_inverted_index.aureus | 16 |
| abstract_inverted_index.model. | 46 |
| abstract_inverted_index.recent | 30 |
| abstract_inverted_index.study. | 208 |
| abstract_inverted_index.within | 37, 115, 176, 183, 192 |
| abstract_inverted_index.(1/189) | 267 |
| abstract_inverted_index.(3/109) | 264 |
| abstract_inverted_index.(6/563) | 223 |
| abstract_inverted_index.Empiric | 322 |
| abstract_inverted_index.Methods | 69 |
| abstract_inverted_index.Overall | 285 |
| abstract_inverted_index.Results | 197 |
| abstract_inverted_index.between | 94 |
| abstract_inverted_index.center. | 82 |
| abstract_inverted_index.culture | 113 |
| abstract_inverted_index.empiric | 11, 67 |
| abstract_inverted_index.factors | 23 |
| abstract_inverted_index.groups, | 246, 273 |
| abstract_inverted_index.locally | 44 |
| abstract_inverted_index.medical | 81 |
| abstract_inverted_index.non-ICU | 133, 225, 245, 272 |
| abstract_inverted_index.nursing | 310 |
| abstract_inverted_index.outcome | 137, 152 |
| abstract_inverted_index.overall | 210, 319 |
| abstract_inverted_index.present | 104 |
| abstract_inverted_index.primary | 136 |
| abstract_inverted_index.receipt | 33 |
| abstract_inverted_index.screen, | 125 |
| abstract_inverted_index.skilled | 309 |
| abstract_inverted_index.suggest | 10 |
| abstract_inverted_index.without | 297 |
| abstract_inverted_index.(16/490) | 217 |
| abstract_inverted_index.(9/457). | 255 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Authors: | 342 |
| abstract_inverted_index.National | 2 |
| abstract_inverted_index.Patients | 83 |
| abstract_inverted_index.Subgroup | 165 |
| abstract_inverted_index.academic | 80 |
| abstract_inverted_index.admitted | 93, 334 |
| abstract_inverted_index.analyses | 166 |
| abstract_inverted_index.clinical | 3, 64 |
| abstract_inverted_index.combined | 276 |
| abstract_inverted_index.comorbid | 303 |
| abstract_inverted_index.complete | 121 |
| abstract_inverted_index.criteria | 205 |
| abstract_inverted_index.included | 86 |
| abstract_inverted_index.negative | 157 |
| abstract_inverted_index.obtained | 114 |
| abstract_inverted_index.patients | 20, 58, 146, 171, 202, 220, 228, 293, 299, 333 |
| abstract_inverted_index.practice | 4 |
| abstract_inverted_index.reported | 344 |
| abstract_inverted_index.unlikely | 327 |
| abstract_inverted_index.1/01/2021 | 95 |
| abstract_inverted_index.admission | 128, 306 |
| abstract_inverted_index.bacterial | 106 |
| abstract_inverted_index.determine | 155 |
| abstract_inverted_index.excluding | 298 |
| abstract_inverted_index.facility. | 311 |
| abstract_inverted_index.including | 24 |
| abstract_inverted_index.inclusion | 204 |
| abstract_inverted_index.infection | 56, 144, 214, 289 |
| abstract_inverted_index.isolation | 27, 175 |
| abstract_inverted_index.patients, | 251 |
| abstract_inverted_index.patients. | 226 |
| abstract_inverted_index.performed | 169 |
| abstract_inverted_index.pneumonia | 8 |
| abstract_inverted_index.regarding | 66 |
| abstract_inverted_index.screening | 281, 314 |
| abstract_inverted_index.secondary | 151 |
| abstract_inverted_index.treatment | 12 |
| abstract_inverted_index.validated | 45 |
| abstract_inverted_index.warranted | 330 |
| abstract_inverted_index.3/18/2023, | 97 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 284 |
| abstract_inverted_index.admission, | 119, 180, 187 |
| abstract_inverted_index.admission. | 196 |
| abstract_inverted_index.antibiotic | 190, 259 |
| abstract_inverted_index.associated | 316 |
| abstract_inverted_index.conditions | 304 |
| abstract_inverted_index.guidelines | 5 |
| abstract_inverted_index.isolation, | 233 |
| abstract_inverted_index.mechanical | 181 |
| abstract_inverted_index.pneumonia, | 107 |
| abstract_inverted_index.predictive | 158 |
| abstract_inverted_index.prevalence | 234, 252, 261, 286 |
| abstract_inverted_index.screening. | 164 |
| abstract_inverted_index.stratified | 126 |
| abstract_inverted_index.treatment. | 68 |
| abstract_inverted_index.underlying | 302 |
| abstract_inverted_index.vancomycin | 325 |
| abstract_inverted_index.ventilated | 250 |
| abstract_inverted_index.Disclosures | 340 |
| abstract_inverted_index.antibiotics | 36 |
| abstract_inverted_index.descriptive | 76 |
| abstract_inverted_index.disclosures | 345 |
| abstract_inverted_index.recipients, | 260 |
| abstract_inverted_index.respiratory | 26, 110, 173, 231 |
| abstract_inverted_index.ventilation | 182 |
| abstract_inverted_index.hospitalized | 19, 59, 147, 294 |
| abstract_inverted_index.institution. | 339 |
| abstract_inverted_index.mechanically | 249 |
| abstract_inverted_index.respectively. | 247, 274 |
| abstract_inverted_index.Staphylococcus | 15 |
| abstract_inverted_index.observational, | 74 |
| abstract_inverted_index.retrospective, | 73 |
| abstract_inverted_index.decision-making | 65 |
| abstract_inverted_index.hospitalization | 31 |
| abstract_inverted_index.population-based, | 75 |
| abstract_inverted_index.community-acquired | 7 |
| abstract_inverted_index.methicillin-resistant | 14 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 3 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/16 |
| sustainable_development_goals[0].score | 0.4300000071525574 |
| sustainable_development_goals[0].display_name | Peace, Justice and strong institutions |
| citation_normalized_percentile.value | 0.32175369 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |